The impact of HER2-low status on pathological complete response and disease-free survival in early-stage breast cancer. Sen GA, Aydin E, Guliyev M, Oztas NS, et al. BMC Cancer 2024;24:1311.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sen GA, Aydin E, Guliyev M, Oztas NS, et al. The impact of HER2-low status on pathological complete response and disease-free survival in early-stage breast cancer. BMC Cancer 2024;24:1311.
PMID: 39448928